IMPORTANCE Neurophysiologic measures of early auditory information processing (EAP) are used as endophenotypes in genomic studies and biomarkers in clinical intervention studies. Research in schizophrenia has established correlations among measures of EAP, cognition, clinical symptoms, and functional outcome. Clarifying these associations by determining the pathways through which deficits in EAP affect functioning would suggest when and where to therapeutically intervene.
S chizophrenia is characterized by widespread deficits that range from abnormalities in basic information registration and processing 1, 2 to impairments in cognitive [3] [4] [5] and psychosocial 6 domains. Given the current evidence that cognitive impairments are robust predictors of functional outcome, 7, 8 there is renewed interest in the longstanding challenge of understanding how deficits in information processing contribute to cognitive and psychosocial impairments in schizophrenia. [9] [10] [11] [12] In this article, we use structural equation modeling 13 to refine a theory characterizing the mediating pathways that relate impaired information processing to poor functional outcome. 14 Clarifying the associations between information processing and outcome can improve the use of novel procognitive therapeutics, such as pharmacologic enhancement, 15 neuroplasticity-based cognitive training, [16] [17] [18] [19] and neurostimulation, 20,21 by informing clinicians and researchers when and where to intervene. Auditory information processing deficits have been consistently identified in patients with chronic, recent-onset, and unmedicated schizophrenia and in individuals at high clinical risk for developing psychosis.
14 Neurophysiologic measures of early auditory information processing (EAP) in schizophrenia correlate with cognition [22] [23] [24] and functional outcome, 25-28 can be feasibly measured across diverse settings, 29 and thus have promising applications as endophenotypes in genomic studies and as biomarkers in clinical outcome studies. 14, [29] [30] [31] [32] [33] [34] [35] [36] In one commonly used EAP assessment paradigm, electroencephalographic recordings are collected while participants passively listen to standard stimuli interspersed by deviant oddball sounds. The electroencephalographic recordings are dominated by 3 peaks labeled mismatch negativity (MMN), P3a, and reorienting negativity (RON). The MMN is thought to index preattentive processing of sounds, the P3a is thought to reflect the transition from perception and sensory registration to focal attention or orienting to the stimulus, and the RON is thought to reflect reorienting of attention after distraction. 37 Together, these components reflect processes underlying auditory perception, auditory learning and memory, and other complex cognitive functions. 14, 38, 39 The MMN, P3a, and RON arise from broadly distributed patterns of neural activation 28, 40 and are sensitive to N-methyl-D-aspartate receptor functioning 41 -a key component of long-term neuroplasticity.
Reduced MMN, P3a, and RON amplitudes, as well as longer peak latencies, are common features of schizophrenia. 14, 33 A previous analysis of data from the Consortium on the Genetics of Schizophrenia 2 (COGS-2) 29 found EAP impairments in schizophrenia with correlations detected between EAP and global cognition, clinical symptoms, and functional outcome, findings that support the increasing literature. 25, 26, [42] [43] [44] [45] [46] Although such correlations underscore the functional significance of EAP deficits, they do not disentangle the multivariate associations among domains or allow for modeling the cumulative effects of impaired information processing.
Research has suggested that measures of EAP are sensitive to procognitive behavioral and pharmacologic therapies 47, 48 and that changes in EAP might predict improvements in more distant treatment outcomes, that is, outcomes (eg, work functioning) that are indirectly affected by EAP. This finding is supported by a bottom-up model that suggests deficits in EAP lead to impairments in auditory attention, language, and memory 14, 22 and that diminished cognition subsequently contributes to defeatist beliefs and other social cognitive phenomena, negative symptoms, and, ultimately, poor functional outcome.
9,49
Social cognition and clinical symptoms-mainly experiential negative symptoms (ie, avolition and anhedonia) more so than expressive negative symptoms (ie, affective blunting or flattening and alogia) We sought to further clarify the multidomain pathways relating EAP to functional outcome in schizophrenia using a large sample of patients who participated in the COGS-2 study. In particular, we aimed to examine whether cognition and negative symptoms mediate the EAP-to-outcome association. We also sought to estimate the extent to which enhancement of basic information processing might improve both the cognitive and psychosocial functioning of patients with schizophrenia to provide a benchmark for future intervention studies. We hypothesized that impairments in EAP would affect negative symptoms via task modality-specific deficits in cognition (hypothesis 1). That is, we believed that measures of EAP would be more closely linked to auditory rather than visual modes of stimulus presentation. Consistent with previous results, we also hypothesized that negative symptoms would affect functional outcome via separate pathways, reflecting a dissociation of experiential and expressive negative symptoms (hypothesis 2). Last, given that EAP is thought to indirectly influence distant outcomes, we hypothesized that impairments in EAP would indirectly affect functional outcome via a single pathway running through cognition and negative symptoms (hypothesis 3).
Methods

Participants
Participants included 1415 unrelated outpatients diagnosed with schizophrenia or schizoaffective disorder who were recruited as part of COGS-2 from July 1, 2010, through January 31, 2014. A total of 1020 participants (72.1%) reported being prescribed atypical antipsychotics, 108 (7.6%) reported being prescribed typical antipsychotics, 135 (9.5%) reported being prescribed both, and 152 (10.7%) reported being prescribed no antipsychotic medication. 
Negative Symptoms
Negative symptoms were assessed using the Scale for the Assessment of Negative Symptoms (SANS). 68 The SANS includes 5 interviewer-rated global ratings: affective flattening or blunting, alogia, avolition or apathy, anhedonia or asociality, and attention. For all SANS items, higher scores indicate more symptoms. Research suggests that negative symptoms often separate into expressive and experiential factors.
9,69,70
Attention ratings were not included in the analyses.
Functional Outcome
Functional outcome was assessed using the Role Functioning Scale (RFS). 71 The RFS includes 4 interviewer-rated role functions: working productivity, independent living and selfcare, immediate social network relationships, and extended social network relationships. For all RFS items, higher scores indicate better functioning.
Statistical Analysis
Structural equation modeling 13, 72 was used to summarize associations among measures described in the previous sections using latent variables and then to test the plausibility of causal associations among these constructs. Our measurement model (M0) consisted of EAP, cognition for stimuli presented aurally (hereinafter auditory cognition), cognition for stimuli presented visually (hereinafter visual cognition), expressive negative symptoms, experiential negative symptoms, and functional outcome. To determine whether causal effects were mediated by specific vs nonspecific pathways, path models additionally assumed higher-order cognition (hereinafter cognition) and higher-order negative symptoms (hereinafter negative symptoms) constructs. We fitted a series of path models to the data that were designed to test the plausibility of the 3 causal hypotheses. Models are shown in Figure 1 . The specific deficits model (M1) assumed that impairments in EAP affect task modality-specific deficits in cognition-which in turn increase negative symptoms-and that expressive and experiential negative symptoms directly affect functional outcome through separate pathways. We then fitted competing models to the data to test specific hypotheses. In the nonspecific cognitive deficits model (M2), which was designed to test hypothesis 1, we restricted the causal pathway between EAP and negative symptoms to run through the cognition factor alone. In the nonspecific negative symptoms model (M3), which was designed to test hypothesis 2, we restricted the causal pathway between cognition and functional outcome to run through the negative symptoms factor alone. In the direct EAP model (M4), which was designed to test hypothesis 3, we allowed EAP to have a direct (ie, nonmediated) effect on functional outcome.
Model parameters were estimated using the latent variable analysis (lavaan) package for R. 73 
Results
Participants included 1415 unrelated outpatients diagnosed with schizophrenia or schizoaffective disorder who among the indicators are reported in Figure 2 (for descriptive statistics, see the eTable in the Supplement).
Model fit statistics are reported in the Table. The M0 model provided acceptable fit. The M0 parameter estimates are shown in Figure 3 . Our initial path model (M1) (eFigure 1 in the Supplement) also provided an acceptable fit. Therefore, we continued with tests of the primary hypotheses. No significant difference was found in model fit comparing M1 and M2 (eFigure 2 in the Supplement), and the latter produced better or equal CFI, RMSEA, AIC, and BIC statistics. Thus, the data do not support the hypothesis that impairments in EAP affect negative symptoms via task modality-specific deficits in cognition.
Do Negative Symptoms Affect Functional Outcome via Separate Experiential and Expressive Negative Symptoms Pathways?
The M1 model was distinguishable from and fit the data significantly better than M3 (eFigure 3 in the Supplement). The former also produced better CFI, RMSEA, AIC, and BIC statistics. Thus, the data support the hypothesis that negative symptoms affect functional outcome via separate experiential and expressive negative symptoms pathways. Although distinguishable, no significant difference was found in model fit comparing M1 and M4 (eFigure 4 in the Supplement); however, the latter produced better CFI, RMSEA, AIC, and BIC statistics. Thus, there is evidence to suggest that, counter to hypothesis 3, EAP has a direct effect on functional outcome. To explore this further, we noted that cognition was more strongly associated with functional outcome than with negative symptoms (Figure 3) , which is not consistent with the assumption that negative symptoms fully mediate the association between cognition and functional outcome. This finding suggests that an omitted pathway between cognition and functional outcome could be the cause of the nearly significant pathway between EAP and functional outcome. To determine this, a fifth model, the direct-cognition model (M5) (eFigure 5 in the Supplement), was tested with a direct path from cognition to functional outcome estimated. M5 was distinguishable from and fit the data significantly better than M1. M5 also produced better CFI, RMSEA, AIC, and BIC statistics when compared with M1 and M4, suggesting that cognition rather than EAP has a direct effect on functional outcome.
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What Are the Pathways From EAP to Functional Outcome?
We next fitted the final model that combined all previously accepted hypotheses and ad hoc findings (M6). The parameter estimates for this model are reported in Figure 4 . Early auditory information processing has a direct effect on cognition that is not specific to auditory or visual task modalities. In turn, poor cognition has direct and indirect effects on functional outcome. The indirect effect is mediated by negative symptoms in general and experiential negative symptoms in particular. The M6 model was distinguishable from and fit the data significantly better than M1 and produced the best CFI, RMSEA, AIC, and BIC values of all models fitted to the data.
What Is the Effect of EAP on Cognition and Functional Outcome?
On the basis of the M6 parameter estimates, the effect (in standardized units) of EAP on cognition was estimated to be β = 0.37 (P < .001), and the total effect of EAP on functional outcome was estimated to be β = 0.14 (P < .001). That is, in the current sample, there was an approximately one-third SD difference in cognition and a one-seventh SD difference in functional outcome for every SD difference in EAP. 
Discussion
The present study clarified the multivariate associations among measures of EAP, cognition, negative symptoms, and functional outcome in schizophrenia. Results supported the hypothesized information processing, bottom-up model whereby EAP deficits contribute to cognitive impairments, 14, 22 which are followed by negative symptoms and reduced functional outcome. 9,49 Consistent with our hypothesis, experiential negative symptoms exerted a much stronger effect on functional outcome than did expressive negative symptoms (hypothesis 2). We also found that the effect of EAP on functional outcome was fully mediated by cognition and negative symptoms (hypothesis 3), but results suggest separate pathways that involve or bypass negative symptoms. Impairments in EAP appear to be comparably associated with auditory and visual domains of cognitive functioning. Because EAP arises from a broadly distributed network, 28,40 results lend support to the view that measures of EAP generally reflect impaired brain functioning rather than a specific deficit in auditory information processing. This pattern of results has potential implications for biomarker guided treatment development. Until recently, the prevailing view of schizophrenia has been that cognitive impairments are largely immutable to rehabilitative efforts and serve as a bottleneck to optimal psychosocial functioning. Findings that cognitive impairments are not fixed but can be enhanced via pharmacologic, 15 neuroplasticity-based cognitive training, [16] [17] [18] [19] 79 Additional research is needed to characterize the neural substrates that engender a positive treatment response and can be leveraged to guide a mechanistically informed, personalized intervention approach. 80 
Limitations
The results of this study should be interpreted in light of key limitations. First, we used statistical modeling to explore the 
eAppendix. Estimation Approach eMethods Analyses
The measurement model was identified by the two-indicator rule.
1 Structural models were identified by the recursive rule. 1 Loadings were fixed to be equal when only two indicators were available for a latent variable to avoid instability. Parameter estimates were obtained using a mean-and variance-adjusted weighted least squares (WLSMV) estimator. Missing data were imputed using the semTools package for R. One subject was dropped from the analyses due to missing data on all variables included in the model. The Akaike information criterion (AIC), Bayesian information criterion (BIC), distinguishability ( 2 ), and closeness (z) test statistics were based on maximum likelihood estimation, as they require. We omitted the path between expressive negative symptoms and functional outcome in the final model (M6) because the path was shown to have a non-significant effect in the nonspecific-negative-symptoms model (M3) and because prior research has shown that this path is unnecessary when experiential negative symptoms have a direct effect on functional outcome.
